Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- Pakistan
- Region
- Asia
Regulatory licences
- DMLName on licence: Nicholas Pharmaceuticals
Registered products
25 products
Alpa-ket Tabletsa-Ketoanalogue to isoleucine (Calcium-salt) : 67 mg; a-Ketoanalogue to leucine (Calcium-salt) : 101 mg; a-Ketoanalogue to phenylalanine (Calcium-Salt) : 68 mg; a-Ketoanalogue to valine (Calcium-Salt) : 86 mg; a-hydroxyanalogue to DL-methionine (Calcium-Salt) : 59 mg; L-lysine acetate 105mg corresponding to L-lysine : 75 mg; L-threonine : 53 mg; L-tryptophan : 23 mg; L-histidine : 38 mg; L-tyrosine : 30 mg; Total nitrogen content per tablet : 36 mg; Calcium content per tablet 1.25mmol : 50 mgCefzect 1gm Injection IMCeftriaxone 1gm1gmCefzect 1gm Injection IVCeftriaxone 1gm1gmCefzect 250mg Injection IMCeftriaxone 250mg250mgCefzect 250mg Injection IVCeftriaxone 250mg250mgCefzect 2gm Injection IVCeftriaxone 2gm2gmCefzect 500mg Injection IMCeftriaxone 500mg500mgCefzect 500mg Injection IVCeftriaxone 500mg500mgFlucinic Topical Oil 0.01%Fluocinolone Acetonide: 0.11 mg0.11 mgNaftoxime 1gm InjectionCefotaxime (as sodium) 1gm1gmNaftoxime 250mg InjectionCefotaxime (as sodium) 250mg250mgNaftoxime 2gm InjectionCefotaxime (as sodium) 2gm2gm